Scientific Agenda

Friday, February 19, 2010

7:00 am	Breakfast
8:00 am	Welcome and introduction Moderator: James Epstein, MD

Session I: Breast Cancer
Moderator: Christy A. Russell, MD

8:10 am	Optimal chemotherapy regimens for breast cancer Ruth M. O’Regan, MD
8:35 am	Management of metastatic HER2-positive breast cancer Debu Tripathy, MD
9:00 am	Case discussion: Patient who fails first-line trastuzumab in the metastatic setting Moderator: Christy Russell, MD Panel: Debu Tripathy, MD and Ruth M. O’Regan, MDr
9:20 am	Q & A
9:25 am	Break

Session II: Gastrointestinal Cancers
Moderator: Axel Grothey, MD

9:45 am	Adjuvant therapy of CRC: Has anything changed? Alan P Venook, MD
10:10 am	Emerging trends in the management of upper gastrointestinal tract adenocarcinoma David H. Ilson, MD, PhD
10:35 am	Case discussions plus Q & A Moderator: Axel Grothey, MD Panel: Alan Venook, MD, UCSF Medical Center, San Francisco, California, and David H. Ilson, MD, PhD
11:00 am	Lunch symposium
12:45 pm	Symposium adjourns

Session III: Orphan Cancers
Moderator: James Epstein, MD

1:00 pm	Clinical updates in T-cell lymphoma James 0. Armitage, MD
1:20 pm	Advances in the management of thyroid cancers Marcia S. Brose, MD, PhD
1:40 pm	Melanoma: Improving clinical outcomes through advances in immunotherapeutics and targeted therapy Antoni Ribas, MD, PhD
2:00 pm	Biliary tract cancer: Has the standard of care changed? Axel Grothey, MD
2:20 pm	Updates in gynecologic oncology Bradley J. Monk, MD, FACOG, FACS
2:40 pm	Q & A
3:00 pm	Break

Session IV: Meet the Experts (parallel with session V)
Concurrent sessions

3:15 pm	Session A: Managing myeloma in first and subsequent relapses Robert Z. Orlowski, MD, PhD Session B: Managing follicular lymphoma: Mundane or maddening? Morton Coleman, MD, FACP
4:15 pm	Meet the expert adjourns

Session V: Oncology Symptom Management (parallel with session IV)
Moderator: Charles L. Loprinzi, MD

3:15 pm	Nonestrogenic management of hot flashes Charles L. Loprinzi, MD
3:40 pm	What to tell your patients about vitamins and complementary medications Sandra E. Kurtin, RN
4:05 pm	Prevention/treatment of chemotherapy-induced neuropathy Axel Grothey, MD
4:30 pm	Adjourn
5:30 pm - 7:00 pm	Reception

Saturday, February 20, 2010

7:00 am	Breakfast
8:00 am	Welcome Christy A. Russell, MD

Session VI: Hematologic Malignancies
Moderator: Robert Z. Orlowski, MD, PhD

8:05 am	Front-line therapy for newly diagnosed myeloma Robert Z. Orlowski, MD, PhD
8:30 am	The remaining challenges in chronic leukemia Neil Shah, MD, PhD
8:55 am	Acute leukemia/MDS: Clinical genomic and molecular factors in therapeutic planning Neil Shah, MD, PhD
9:20 am	Case discussion plus Q & A Moderator: Robert Z. Orlowski, MD, PhD Panel: Neil Shah, MD, PhD and Elihu Estey, MD
9:50 am	Break

Session VII: Genitourinary Oncology
Moderator: Christy A. Russell, MD

10:10 am	Optimal sequencing and combining of current and emerging therapies in RCC Robert Dreicer, MD, FACP
10:35 am	Current and emerging concepts in the management of patients with castrate resistant prostate cancer Dean F. Bajorin, MD
11:00 am	Case discussion plus Q & A Moderator: Christy A. Russell, MD Panel: Robert Dreicer, MD, FACP and Dean F. Bajorin, MD
11:30 am	Session adjourns

Lunch Symposium on Challenges in the Oncology Healthcare Community

11:45 am	Serve lunch
12:15 pm	Reimbursement issues ION representative
12:40 pm	U.S. healthcare: Policy and politics Joseph S. Bailes, MD
1:05 pm	Symposium adjourns

Session VIII: Lung Cancer
Moderator: Corey J. Langer, MD, FACP

1:20 pm	Adjuvant therapy for NSCLC: Impact of recent clinical trial updates on community practice Suresh S. Ramalingham, MD
1:45 pm	Maintenance therapy for advanced NSCLC: When, what, why, and what’s left after post-maintenance relapse Mark A. Socinski, MD
2:10 pm	Novel targets and agents in development for NSCLC Ramaswamy Govindan, MD
2:35 pm	Case discussion Moderator: Corey J. Langer, MD, FACP Panel: Suresh S. Ramalingam, MD, Mark A. Socinski, MD, and Ramaswamy Govindan, MD
2:55 pm	Q & A
3:00 pm	Break

Meet the Experts
Concurrent sessions

3:15 pm	Session A: Head and neck cancer Corey J. Langer, MD, FACP Session B: Small cell lung cancer Mark A. Socinski, MD
4:15 pm	Meet the expert adjourns